| Ticker Symbol: | ZMH |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 345 East Main Street Warsaw IN 46580 574-267-6131 |
| CEO/President: | Raymond J. Elliott |
| Industry: | Medical Products / Standard Industry Code: 3842 |
| Description: | Zimmer is a global leader in the design, development, manufacturing and market of reconstructive orthopaedic implants and fracture management products. Orthopaedic reconstruction implants restore joint function lost to disease or trauma in joints such as knees, hips, shoulders and elbows. Fracture management products are devices used primarily to reattach or stabilize damaged bone and tissue to support the body\'s natural healing process. |
| Shares Outstanding: | 231,490 (000) | Market Value: | 11,914,720 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 74.99% | Number of Inst.Shareholders: | 1.00% |
| Last Quarter Sales: | 1079.50 ($Mil.) | Last Quarter Net Income: | 227.10 ($Mil.) |
| Last Quarter EPS: | 1.03 | P/E Ratio: | 13 |
| Most Recent Earnings: | 0.99 on 07/22/08 | Earnings Per Share: | 3.32 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |


| BOSTON SCIENTIF | -47.50 | 7.31 | |
| MEDTRONIC INC | -32.50 | 40.00 | |
| BAXTER INTL INC | -8.30 | 56.10 | |
| ST. JUDE MEDICA | -30.50 | 32.52 | |
| STRYKER CP | -35.60 | 51.12 |
